Glen Dalakian is a member of Ropes & Gray’s litigation and enforcement practice group. He focuses his practice on civil and criminal government investigations, and related litigation. Glen’s experience includes representing clients facing antitrust investigations, False Claims Act investigations, and data privacy litigation. He represents clients across the healthcare and life sciences industry, including hospital systems, pharmaceutical companies, healthcare providers, and academic institutions facing government investigations. Glen’s work includes client advocacy before the U.S. Department of Justice, the Federal Trade Commission, and state enforcement authorities.
Glen maintains an active pro bono practice and has represented individuals in criminal cases through the Southern District of New York's Criminal Justice Act Panel. He also advocates for clients seeking refugee resettlement.
Prior to joining Ropes & Gray, Glen managed an international venture capital fund and worked as a business journalist based in Beirut, Lebanon, where he reported on entrepreneurship across the Middle East. He also previously worked at The Legal Aid Society, the U.S. Department of State, the Federal Reserve, and on Capitol Hill. During law school, Glen served as executive notes editor of the Fordham Law Review.
Experience
- Representing a national home healthcare company facing an FCA investigation into reimbursement claims submitted to government payors.
- Representing a public university facing an FCA investigation into alleged false claims submitted to NIH by a faculty researcher.
- Representing a regional hospital system responding to multidistrict litigation related to national data breach incident affecting millions of patients.
- Representing an international venture capital fund responding to subpoenas by the FTC to testify in a high-profile antitrust lawsuit.
- Represented one of the largest home healthcare companies in an industrywide investigation by the DOJ Antitrust Division into price-fixing allegations related to payor rate negotiations, ultimately resulting in a declination to indict by the government.
- Represented an international pharmaceutical company responding to a Second Request by the FTC related to its proposed licensing agreement with a drug developer.
- Represented a large hospital in New Jersey responding to a Second Request by the FTC related to its proposed acquisition by another hospital system.
- Counseled an academic hospital system considering a merger with another hospital system regarding antitrust risks and potential merger review.
- Conducted client employee trainings about antitrust risks in the healthcare space.
- Represented directors of international media company facing litigation brought by former stockholders of Viacom and former stockholders of CBS challenging the multi-billion dollar merger of Viacom and CBS, resulting in settlement prior to trial.
- Conducted an internal investigation on behalf of a special committee of the board of a pharmaceutical company into potential board member and leadership misconduct.
- Conducted an internal investigation on behalf of the board of a large private equity fund into misconduct and mismanagement by portfolio company leadership.
- Represented major financial firm responding to an SEC investigation into SPAC transaction.
- Represented criminal defendant facing federal money laundering conspiracy prosecution.
- Represented refugee families seeking asylum, leading to resettlement in the United States.